![Challenges of developing anti-drug antibody & concentration (PK or PD) assays for liposomal transgene enzymes on an automated immunoassay platform Challenges of developing anti-drug antibody & concentration (PK or PD) assays for liposomal transgene enzymes on an automated immunoassay platform](https://cdn.insights.bio/uploads/Figure/CC_GYPT_301WT_Figure1.png)
Challenges of developing anti-drug antibody & concentration (PK or PD) assays for liposomal transgene enzymes on an automated immunoassay platform
![Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study | BMC Medical Research Methodology | Full Text Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study | BMC Medical Research Methodology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12874-022-01742-2/MediaObjects/12874_2022_1742_Fig2_HTML.png)
Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study | BMC Medical Research Methodology | Full Text
![Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis | Bioanalysis Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis | Bioanalysis](https://www.future-science.com/cms/10.4155/bio.13.302/asset/images/medium/figure3.gif)
Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis | Bioanalysis
![Pharmacokinetics and Immunogenicity Investigation of a Human Anti-Interleukin-17 Monoclonal Antibody in Non-Naïve Cynomolgus Monkeys | Drug Metabolism & Disposition Pharmacokinetics and Immunogenicity Investigation of a Human Anti-Interleukin-17 Monoclonal Antibody in Non-Naïve Cynomolgus Monkeys | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/43/5/762/F2.large.jpg)
Pharmacokinetics and Immunogenicity Investigation of a Human Anti-Interleukin-17 Monoclonal Antibody in Non-Naïve Cynomolgus Monkeys | Drug Metabolism & Disposition
![The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity | British Journal of Cancer The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01684-4/MediaObjects/41416_2021_1684_Fig3_HTML.png)
The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity | British Journal of Cancer
![Evaluating and Reporting the Immunogenicity Impacts for Biological Products—a Clinical Pharmacology Perspective | The AAPS Journal Evaluating and Reporting the Immunogenicity Impacts for Biological Products—a Clinical Pharmacology Perspective | The AAPS Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1208%2Fs12248-015-9857-y/MediaObjects/12248_2015_9857_Fig3_HTML.gif)
Evaluating and Reporting the Immunogenicity Impacts for Biological Products—a Clinical Pharmacology Perspective | The AAPS Journal
![Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulation. - Abstract - Europe PMC Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulation. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3691419/bin/12248_2013_9468_Fig2_HTML.jpg)
Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulation. - Abstract - Europe PMC
![Acid dissociation to detect ADA and drug. 1, Illustration of a sample... | Download Scientific Diagram Acid dissociation to detect ADA and drug. 1, Illustration of a sample... | Download Scientific Diagram](https://www.researchgate.net/profile/Boris-Gorovits/publication/236094891/figure/fig1/AS:367422830858243@1464611837830/Acid-dissociation-to-detect-ADA-and-drug-1-Illustration-of-a-sample-containing-ADA_Q320.jpg)
Acid dissociation to detect ADA and drug. 1, Illustration of a sample... | Download Scientific Diagram
![Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study | BMC Medical Research Methodology | Full Text Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study | BMC Medical Research Methodology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12874-022-01742-2/MediaObjects/12874_2022_1742_Fig3_HTML.png)
Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study | BMC Medical Research Methodology | Full Text
![A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing - Liao - 2020 - British Journal of Clinical A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing - Liao - 2020 - British Journal of Clinical](https://bpspubs.onlinelibrary.wiley.com/cms/asset/80303ddd-1980-43b0-b2d0-6856099b5c53/bcp14312-fig-0002-m.jpg)
A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing - Liao - 2020 - British Journal of Clinical
![A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing - Liao - 2020 - British Journal of Clinical A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing - Liao - 2020 - British Journal of Clinical](https://bpspubs.onlinelibrary.wiley.com/cms/asset/99ca0bc8-0399-4fd4-8ef2-c80340543889/bcp14312-fig-0001-m.jpg)
A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing - Liao - 2020 - British Journal of Clinical
![Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drug | Bioanalysis Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drug | Bioanalysis](https://www.future-science.com/cms/10.4155/bio.15.213/asset/images/medium/figure3.gif)